Sie Djohan - Kalbe Farma Management Devel
| KLBF Stock | IDR 1,485 20.00 1.37% |
Executive
Mr. Sie Djohan serves as Director of PT Kalbe Farma Tbk since June 5, 2017. He obtained a degree in Pharmacy from Universitas Indonesia in 1990. He started his career in Kalbe Group acting as Group Marketing Manager of PT Dankos Farma in 19962001, then acted as Assistant Director of Marketing of PT Dankos Farma in 20012006. In 20062007 he acted as Assistant Director of Business Development Management System, PT Kalbe Farma Tbk, and in year 2007 present he acts as Director of Business Development, Management System Regulatory Affairs of PT Kalbe Farma Tbk. since 2017.
| Age | 56 |
| Tenure | 7 years |
| Phone | 62 21 4287 3888 |
| Web | https://www.kalbe.co.id |
Kalbe Farma Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1673 %, meaning that it generated $0.1673 on every $100 dollars invested by stockholders. Kalbe Farma's management efficiency ratios could be used to measure how well Kalbe Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Muhamad Basri | Astra International Tbk | 54 | |
| Anthony Nightingale | Astra International Tbk | 72 | |
| Benjamin Keswick | Astra International Tbk | 47 | |
| Benny Santoso | PT Indofood Sukses | 61 | |
| David Newbigging | Astra International Tbk | 47 | |
| Bambang Subianto | PT Indofood Sukses | 74 | |
| Franciscus Kesuma | United Tractors Tbk | 61 | |
| John Witt | Astra International Tbk | 56 | |
| Sin Chiew | Astra International Tbk | 57 | |
| John Ryan | PT Indofood Sukses | 53 | |
| Christopher Young | PT Indofood Sukses | 61 | |
| Mark Greenberg | Astra International Tbk | 50 | |
| Sara Loebis | United Tractors Tbk | 53 | |
| Ami Tantri | Semen Indonesia Persero | N/A | |
| Utomo Josodirdjo | PT Indofood Sukses | 89 | |
| Adi Leman | PT Indofood Sukses | 65 | |
| Sri Hadiputranto | Astra International Tbk | 76 | |
| Pong Hon | PT Indofood Sukses | 56 | |
| Victor Suhendra | PT Indofood Sukses | N/A | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 |
Kalbe Farma Tbk Leadership Team
Elected by the shareholders, the Kalbe Farma's board of directors comprises two types of representatives: Kalbe Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kalbe. The board's role is to monitor Kalbe Farma's management team and ensure that shareholders' interests are well served. Kalbe Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kalbe Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lanny Soputro, G HR | ||
| Vidjongtius, Director, Corporate Secretary, IR Contact Officer | ||
| Kurniawan Suhartono, Head Unit | ||
| Sie Djohan, Management Devel | ||
| Lukito Gozali, Head Relations |
Kalbe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kalbe Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 95.3 T | |||
| Shares Outstanding | 46.26 B | |||
| Shares Owned By Insiders | 58.08 % | |||
| Shares Owned By Institutions | 15.23 % | |||
| Price To Book | 5.06 X | |||
| Price To Sales | 3.36 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.